In vitro effect of a new cinnamic acid derivative against the epimastigote form of Trypanosoma cruzi

Arzneimittel-Forschung/Drug Research

Volumn 59, Issue 4, 2009, Pages 207-211

  Andreu, Gilberto L Pardo ^a,b   Inada, Natalia M ^c   Pellón, Rolando F ^a   Docampo, Maite L ^a   Fascio, Mirta L ^d   D'Accorso, Norma B ^d   Vercesi, Anibal E ^c  

^a Centro de Quimica Farmaceutica   (Cuba)

^b INSTITUTO DE FARMACIA Y ALIMENTOS   (Cuba)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anti protozoal agents; Chagas' disease; Cinnamic acid; Epimastigotes; Mitochondria; Oxidative stress; Trypanosoma cruzi

Indexed keywords

CAD 1; CINNAMIC ACID DERIVATIVE; N (1,3 BENZOTHIAZOL 2 YL) 3 (2,5 DIMETHOXYPHENYL) 2 PROPENAMIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; EPIMASTIGOTE; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; TRYPANOSOMA CRUZI;

EID: 66149168381     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296387     Document Type: Article

References (14)

1. Vinhaes MC, Schofield CJ. Trypanosomiasis control: surmounting diminishing returns. Trends Parasitol. 2003;19:112-113.
2. Coura JR, De Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002;97:3-24. (Pubitemid 135746197)
3. Castro JA, Montalto de Mecca M, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). HumExp Toxicol. 2006;25:471-479. (Pubitemid 44384589)
4. Halestrap AP. The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J. 1975;148:85-96.
5. Halestrap AP. Transport of pyruvate and lactate into human erythrocytes: evidence for the involvement of the chloride carrier and a chloride-independent carrier. Biochem J . 1976;156:193-207.
6. Pellón RF, Mamposo T, González E, Calderón O. Synthesis of cinnamic acid derivatives using ethanol as solvent or microwave assisted method. Synth Commun. 2000;30:3769-3774.
7. Denicola-Seoane A, Rubbo H, Prodanov E, Turrens J. Succinate- dependent metabolism in Trypanosoma cruzi epimastigotes. Mol Biochem Parasit. 1992;54:43-50.
8. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of biuret reaction. J Biol Chem. 1949;177:751-766.
9. Gomes A, Fernandes E, Lima JL. Fluorescence probes used for detection of reactive oxygen species. J Biochem Bioph Meth. 2005;65:45-80. (Pubitemid 41827578)
10. Rottenberg H, Wu S. Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. Biochim Biophys Acta. 1998;1404:393-404. (Pubitemid 28470541)
11. Buckner F, Yokoyama K, Lockman J, Aikenhead K, Ohkanda J, Sadilek M, et al. A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents. Proc Natl Acad Sci USA. 2003;100:15149-15153. (Pubitemid 37518031)
12. Menna-Barreto RFS, Henriques-Pons A, Pinto AV, Morgado- Diaz JA, Soares MJ, De Castro SL. Effect of a b-lapachone- derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. J Antimicrob Chemoth . 2005;56:1034-1041. (Pubitemid 43009816)
13. Piacenza L, Florencia I, Alvarez MN, Peluffo G, Taylor MC, Kelly JM, et al. Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression. Biochem J. 2007;403:323-334. (Pubitemid 46596589)
14. Viswalingam A, Caldwell J. Cinnamyl anthranilate causes coinduction of hepatic microsomal and peroxisomal enzymes in mouse but not rat. Toxicol Appl Pharmacol. 1997;142:338-347. (Pubitemid 28381025)